NJ State Employees Deferred Compensation Plan’s Puma Biotechnology PBYI Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,000	Closed	-$271K	–	556
2019 Q1	$271K	Sell	7,000 -3,000	-30%	-$91.6K	0.05%	456
2018 Q4	$204K	Hold	10,000	–	–	0.04%	458
2018 Q3	$458K	Hold	10,000	–	–	0.08%	343
2018 Q2	$592K	Hold	10,000	–	–	0.11%	260
2018 Q1	$680K	Buy	10,000 +2,000	+25%	+$150K	0.12%	235
2017 Q4	$791K	Sell	8,000 -1,000	-11%	-$112K	0.14%	209
2017 Q3	$1.08M	Buy	9,000 +4,000	+80%	+$372K	0.2%	139
2017 Q2	$437K	Sell	5,000 -4,167	-45%	-$233K	0.08%	309
2017 Q1	$341K	Hold	9,167	–	–	0.06%	319
2016 Q4	$282K	Hold	9,167	–	–	0.06%	315
2016 Q3	$614K	Hold	9,167	–	–	0.13%	244
2016 Q2	$273K	Hold	9,167	–	–	0.06%	316
2016 Q1	$292K	Hold	9,167	–	–	0.06%	317
2015 Q4	$719K	Hold	9,167	–	–	0.15%	227
2015 Q3	$691K	Buy	+9,167	New	+$867K	0.15%	221

Other funds holding PBYI

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's PBYI Position: Q2 2019 in Review

NJ State Employees Deferred Compensation Plan sold out of Puma Biotechnology (PBYI) in Q2 2019, closing a stake of 7,000 shares — an estimated $271K sold.

NJ State Employees Deferred Compensation Plan first reported a position in PBYI in Q3 2015 and held it in 15 quarters. The position peaked at $1.08M in Q3 2017. 139 funds tracked by Wall St. Rank hold PBYI as of Q2 2019.

NJ State Employees Deferred Compensation Plan reported no remaining Puma Biotechnology position as of Q2 2019 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 7,000 Puma Biotechnology shares in Q2 2019, an estimated $271K.
NJ State Employees Deferred Compensation Plan first reported a position in Puma Biotechnology in Q3 2015 and held it in 15 quarters.
NJ State Employees Deferred Compensation Plan's Puma Biotechnology position peaked at $1.08M in Q3 2017.
139 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2019.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2019, filed 24 Jul 2019.